Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $1.5 billion annually; Misonix's proprietary ultrasonic medical devices are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

Find a broker to begin trading MSON now

Company Name Misonix
Market/Symbol NASDAQ: MSON
Recent Price
Market Cap $91.59M
Avg. Daily Vol. (3m) 10,468
Price/Book N/A
Price/Cash Flow 41x
As of May. 22, 2017
*Source: QuoteMedia

Begin trading MSON

 Find Broker

Recent Company Videos

Misonix: Ultrasonic Surgical Tools Improve Safety & Patient Outcomes

Oct. 30, 2015

Dave Gentry, host of "The RedChip Money Report", interviews Michael McManus, Jr., President & CEO of Misonix (NASDAQ: MSON). Learn more at: ...

Misonix Latest News

Ask the CEO

Want more information? View our latest virtual conference.

Receive MSON Email Alerts

*By entering your information you agree to our privacy policy.

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market